Journals / KONURALP TIP DERGİSİ / 2026 / Volume: 18 Issue: 2

Effect of Direct or Indirect Revascularization of the Below-The-Knee Lesions on Clinical Outcomes in Patients with Chronic Limb Threatening Ischemia Treated Based on the Angiosome Concept

Ersan Tatlı(Focus Medical Center)0000-0002-9844-5598
Alper Erkin(Private Academy Hospital)0000-0001-6144-3727
İbrahim Kocayiğit(SAKARYA UNIVERSITY, SCHOOL OF MEDICINE)0000-0001-8295-9837
Pages
—
Publication Date
2026-06-26
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Whenever feasible, direct revascularization should be considered the preferred treatment strategy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To investigate the impact of direct and indirect revascularization, based on the angiosome concept, on major amputation, minor amputation, and wound healing outcomes after endovascular intervention in patients with critical limb ischemia.
📊
Key Findings & Data:Material and Methods: A total of 121 patients with critical limb ischemia and foot ulcer (Rutherford stage 5–6) were evaluated.
💡
Conclusion & Impact:Whenever feasible, direct revascularization should be considered the preferred treatment strategy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Angiosome · critical limb ischemia · direct and indirect revascularization

Abstract

Aim: To investigate the impact of direct and indirect revascularization, based on the angiosome concept, on major amputation, minor amputation, and wound healing outcomes after endovascular intervention in patients with critical limb ischemia. Material and Methods: A total of 121 patients with critical limb ischemia and foot ulcer (Rutherford stage 5–6) were evaluated. During follow-up, 3 patients died, and successful revascularization could not be achieved in 29 patients. The remaining 89 patients were classified according to successful restoration of blood flow to the affected angiosome as direct revascularization (DR, n=59) or indirect revascularization (IR, n=30). Patients were followed for three months for major amputation, minor amputation, and wound healing outcomes. Results: Among 89 successfully revascularized patients (mean age 63.9 ± 10.2 years, 81.6% male), direct angiosome-targeted flow was achieved in 59 patients (66.3%). During follow-up, the DR group had a significantly lower major amputation rate compared to the IR group (10.2% vs 30%, p=0.018). Minor amputation rates were similar between groups (23.7% vs 23.3%, p=0.967), while wound healing was significantly better in the DR group (61% vs 36.7%, p=0.030). Conclusion: Angiosome-guided direct revascularization may reduce major amputation risk and improve wound healing in isolated below-knee lesions. Whenever feasible, direct revascularization should be considered the preferred treatment strategy.

🔖

Cite This Article

Çakmak, A. C., Tatlı, E., Erkin, A., Çakmak, B. S., Kocayiğit, İ. (2026). Effect of Direct or Indirect Revascularization of the Below-The-Knee Lesions on Clinical Outcomes in Patients with Chronic Limb Threatening Ischemia Treated Based on the Angiosome Concept. KONURALP TIP DERGİSİ, Volume: 18 Issue: 2. https://doi.org/10.18521/ktd.1943873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382(9901):1329-40. doi:10.1016/S0140-6736(13)61249-0.
  2. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317-24. doi:10.1001/jama.286.11.1317.
  3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67. doi:10.1016/j.jvs.2006.12.037.
  4. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517-38. doi:10.1016/s0741-5214(97)70045-4.
  5. Mills JL Sr, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220-34.e1-2. doi:10.1016/j.jvs.2013.08.003.
  6. Iida O, Takahara M, Soga Y, Yamauchi Y, Hirano K, Tazaki J, et al. Worse limb prognosis for indirect versus direct endovascular revascularization only in patients with critical limb ischemia complicated with wound infection and diabetes mellitus. Eur J Vasc Endovasc Surg. 2013;46(5):575-82. doi:10.1016/j.ejvs.2013.08.002.
  7. Iida O, Soga Y, Hirano K, Kawasaki D, Suzuki K, Miyashita Y, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg. 2012;55(2):363-70.e5. doi:10.1016/j.jvs.2011.08.014.
  8. Li B, Shaikh F, Zamzam A, Syed MH, Abdin R, Qadura M. The Identification and evaluation of interleukin-7 as a myokine biomarker for peripheral artery disease prognosis. J Clin Med. 2024;13(12):3583. doi:10.3390/jcm13123583.
  9. Hendri, Suhartono R, Kekalih A, Adriani JR, Faruk M. Healing rate comparison of revascularized and non-revascularized diabetic foot ulcers with peripheral arterial disease. Surg Open Sci. 2023;16:235-241. doi:10.1016/j.sopen.2023.11.008.
  10. Luong B, Brown CM, Humphries MD, Maximus S, Kwong M. Assessing the utility of toe arm index and toe pressure in predicting wound healing in patients undergoing vascular intervention. Ann Vasc Surg. 2023;97:221-35. doi:10.1016/j.avsg.2023.08.005.
  11. Alexandrescu VA, Hubermont G, Philips Y, Guillaumie B, Ngongang C, Vandenbossche P, et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther 2008;15(5):580-93. doi:10.1583/08-2460.1.
  12. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010;75(6):830-6. doi:10.1002/ccd.22319.
  13. Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg. 2009;23(3):367-73. doi:10.1016/j.avsg.2008.08.022.
  14. Varela C, Acín F, de Haro J, Bleda S, Esparza L, March JR. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovascular Surg. 2010;44(8):654-60. doi:10.1177/1538574410376601.
  15. Zheng XT, Zeng RC, Huang JY, Pan LM, Su X, Wu ZH, et al. The use of the angiosome concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels. Ann Vasc Surg. 2016;32:41-9. doi:10.1016/j.avsg.2015.09.021.
  16. Lejay A, Georg Y, Tartaglia E, Gaertner S, Geny B, Thaveau F, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28(4):983-9. doi:10.1016/j.avsg.2013.08.026.
  17. Ahmed Z, Raza MZ, Worrall AP, Kheirelseid E, Naughton P, Moneley D, et al. SVS WIfI score as a predictor of amputation after onset of CLI: validation in an Irish tertiary vascular unit. Surgeon. 2023;21(1):48-53. doi:10.1016/j.surge.2022.02.005.
  18. Fossaceca R, Guzzardi G, Cerini P, Cusaro C, Stecco A, Parziale G, et al. Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: is the angiosome model effective? Cardiovasc Intervent Radiol. 2013;36(3):637-44. doi:10.1007/s00270-012-0544-4.